[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366190-105":59,"doc-detail-366190-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-prospective-study-on-the-detection-of-gastric-neoplasms-using-pepsinogen-and-gastrin-17-levels","A Prospective Study on the Detection of Gastric Neoplasms Using Pepsinogen and Gastrin-17 Levels","","This prospective study evaluates whether adding gastrin-17 (G-17) to pepsinogen (PG)–based testing improves detection of gastric neoplasms. GastroPanel results are compared with conventional serum PG assays in consecutive participants tested from May 2023 to August 2024. Among 1,101 individuals, G-17 and low I/II ratios were significant, with cutoffs \u003C6.15 for GastroPanel and \u003C3.005 for the HBI PG assay. The benefit of G-17 addition applies to neoplasms linked to corpus atrophy, while gastrointestinal stromal tumors show no difference.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-prospective-study-on-the-detection-of-gastric-neoplasms-using-pepsinogen-and-gastrin-17-levels/366190/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-prospective-study-on-the-detection-of-gastric-neoplasms-using-pepsinogen-and-gastrin-17-levels/366190.png","ImageObject",300,407,{"name":92,"@type":93},"Đào","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of this prospective study?","Question",{"text":112,"@type":113},"To identify significant test variables by comparing GastroPanel testing (including G-17) with conventional serum PG assays for detecting gastric neoplasms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were participants selected and who was excluded?",{"text":117,"@type":113},"Consecutive individuals who underwent serologic testing from May 2023 to August 2024 were included, while foreigners, gastrectomy patients, renal insufficiency, prior H. pylori eradication, and recent acid suppressant use were excluded.",{"name":119,"@type":110,"acceptedAnswer":120},"What test findings were significant for detecting gastric neoplasms?",{"text":121,"@type":113},"High G-17 levels and low I/II ratios from GastroPanel and from HBI PG assays were significant variables, with specified cutoff values for the I/II ratios.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366190,1791497973,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374402968488,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Gut and Liver  \n[https://doi.org/10.5009/gnl240544](https://doi.org/10.5009/gnl240544)[ ](https://doi.org/10.5009/gnl240544)[pISSN 1976-2283 eISSN 2005-1212](pISSN 1976-2283 eISSN 2005-1212)  \nOriginal Article  \n\n| A Prospective Study on the Detection of Gastric Neoplasms Using Pepsinogen and Gastrin-17 Levels\u003Cbr>Sun-Young Lee1 , Hee-Won Moon2 , Yeon-Sun Ahn2 , Joo Hye Song1 , Jeong Hwan Kim1 , In-Kyung Sung1\u003Cbr>1Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea; 2Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, Korea |  |  |\n| --- | --- | --- |\n| Article Info\u003Cbr>Received November 18, 2024\u003Cbr>Revised December 31, 2024\u003Cbr>Accepted January 9, 2025\u003Cbr>Published online April 11, 2025\u003Cbr>Corresponding Author\u003Cbr>Sun-Young Lee\u003Cbr>ORCID [https://orcid.org/0000-0003-4146-6686](https://orcid.org/0000-0003-4146-6686)[ ](https://orcid.org/0000-0003-4146-6686)[E-mail](E-mail sunyoung@kuh.ac.kr)[ sunyoung@kuh.ac.kr](E-mail sunyoung@kuh.ac.kr) | Background/Aims: GastroPanel tests include gastrin-17 (G-17) levels in addition to pepsinogen (PG) and Helicobacter pylori serology tests. The aim of this study was to identify significant test findings in patients with gastric neoplasms by comparing the findings of GastroPanel tests and conventional serum PG assays.\u003Cbr>Methods: Consecutive individuals who underwent serological testing were included from May 2023 to August 2024. Foreigners and those with gastrectomy, renal insufficiency, previous H. pylori eradication, and recent acid suppressant use were excluded.\u003Cbr>Results: Among the 1,101 participants, 122 were diagnosed with gastric neoplasms. High G-17 levels (odds ratio [OR], 1.030; 95% confidence interval [CI], 1.008 to 1.052), low I/II ratios determined by GastroPanel tests (OR, 0.834; 95% CI, 0.779 to 0.894), and low I/II ratios determined by HBI PG assays (OR, 0.584; 95% CI, 0.511 to 0.668) were significant variables for detecting gastric neoplasms. The cutoff values for low I/II ratios were \u003C6 . 15 (GastroPanel test) and \u003C3 .005 (HBI assay), with no differences in diagnostic performance between the two tests (p=0 .085) . Although the I/II ratio alone was a significant independent variable for detecting early gastric cancers, advanced gastric cancers, adenomas, and neuroendocrine tumors, the G-17 level alone was significant only for adenomas and neuroendocrine tumors. The findings of the patients with gastrointestinal stromal tumors did not differ from those of the controls.\u003Cbr>Conclusions: Blood test findings are useful for detecting gastric neoplasms, except for gastrointestinal stromal tumors. The addition of G-17 levels to PG tests is only beneficial for diagnosing gastric neoplasms associated with corpus atrophy, such as adenoma and neuroendocrine tumors (ClinicalTrials.gov identifier NCT05883345) . (Gut Liver, 2025;19:548-558)\u003Cbr>Key Words: Atrophic gastritis; Stomach neoplasms; Gastrins; Helicobacter pylori; Pepsinogens |  |\n| \u003Cbr>INTRODUCTION |  | between the updated Sydney system classification scoresand the Kyoto classification scores.4,5 |\n| Important factors for the risk stratification of gastric |  | Serum pepsinogen (PG) assays are another method |\n| neoplasms are the severity of atrophy and Helicobacter py- |  | used to quantify the severity of atrophy, in addition to en- |\n| lori infection status. Histology frequently produces false- |  | doscopic and microscopic measurements. In contrast to |\n| negative Giemsa staining findings in the presence of cancer and precancerous lesions, and biopsy specimens are often |  | traditional serum PG assays, GastroPanel (Biohit Oyj, Helsinki, Finland) tests incorporate the measurement of gas- |\n| reported as unavailable for atrophy assessment. 1,2 Conse- |  | trin-17 (G-17), a substance exclusively secreted by the gas- |\n| quently, in East Asia, the Kyoto classification of the gastritis |  | tric antrum. The G-17 level decreases to less than 1 pmol/ |\n| scoring system is pre","cbCaid3kg6GGyPd1","https://ap.wps.com/l/cbCaid3kg6GGyPd1","pdf",556409,11,"English","# Introduction\n# Materials and Methods\n## Study participants\n# Results\n# Conclusions","[{\"question\":\"What is the main purpose of this prospective study?\",\"answer\":\"To identify significant test variables by comparing GastroPanel testing (including G-17) with conventional serum PG assays for detecting gastric neoplasms.\"},{\"question\":\"How were participants selected and who was excluded?\",\"answer\":\"Consecutive individuals who underwent serologic testing from May 2023 to August 2024 were included, while foreigners, gastrectomy patients, renal insufficiency, prior H. pylori eradication, and recent acid suppressant use were excluded.\"},{\"question\":\"What test findings were significant for detecting gastric neoplasms?\",\"answer\":\"High G-17 levels and low I/II ratios from GastroPanel and from HBI PG assays were significant variables, with specified cutoff values for the I/II ratios.\"}]","A Prospective Study on the Detection of Gastric Neoplasms Using Pepsinogen and Gastrin-17 Levels | PDF",1790164160,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/957cfca54413f6d4c9524131a1e7ecd8.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d22f55a04458a34bc741d97bb488cc5.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/086d1390f888b000c860cd91f3c4683c.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e5b99a426da49e5ac6d0a0ceb401729.webp",980,1306]